文献速递睡眠呼吸障碍

中枢性与复杂性睡眠呼吸暂停的发病机制

Pathogenesis of central and complex sleep apnoea.
PubMed 文献 · Respirology · 2016-10-31

本文综述中枢性睡眠呼吸暂停(CSA)的发病机制,指出多数情况下呼吸努力周期性消失是通气化学反射高敏感(即环路增益升高)导致通气振荡的结果,并阐述CSA与阻塞性睡眠呼吸暂停(OSA)的重叠及复杂性睡眠呼吸暂停的概念,同时说明部分情况如婴儿呼吸暂停由低环路增益所致,现有治疗可通过影响环路增益来解释其疗效。

要点

  • 多数CSA由环路增益升高所致,而非呼吸中枢抑制。
  • OSA治疗可揭示CSA,称为复杂性睡眠呼吸暂停。
  • 环路增益受化学敏感性、plant增益和循环延迟影响。

核心结论

  • 多数情况下CSA是通气化学反射高敏感(环路增益升高)导致通气过冲/不足振荡的结果。
  • CSA与OSA存在重叠,OSA治疗可揭示CSA(复杂性睡眠呼吸暂停)。
  • 部分CSA如婴儿呼吸暂停由通气抑制和低环路增益所致。

研究设计与样本

  • 综述,总结中枢性和复杂性睡眠呼吸暂停发病机制的相关证据。

主要发现

  • 周期性呼吸见于婴儿和健康成人高原环境,Cheyne-Stokes呼吸见于心力衰竭。
  • OSA患者存在环路增益升高,中枢性呼吸暂停期间可见咽部狭窄。
  • CPAP、气管切开或口腔矫治器治疗OSA可揭示CSA。
  • 环路增益受化学敏感性增加、血气阻尼降低和肺到化学感受器循环延迟增加影响。
  • 睡眠-觉醒转换和咽扩张肌反应可升高控制器增益,贡献总环路增益和不稳定性。

临床怎么用

  • 理解环路增益大小及不稳定机制可能有助于制定CSA的个体化干预措施。
  • 现有CSA治疗疗效可通过其对环路增益的影响来解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Central sleep apnoea (CSA) - the temporary absence or diminution of ventilatory effort during sleep - is seen in a variety of forms including periodic breathing in infancy and healthy adults at altitude and Cheyne-Stokes respiration in heart failure. In most circumstances, the cyclic absence of effort is paradoxically a consequence of hypersensitive ventilatory chemoreflex responses to oppose changes in airflow, that is elevated loop gain, leading to overshoot/undershoot ventilatory oscillations. Considerable evidence illustrates overlap between CSA and obstructive sleep apnoea (OSA), including elevated loop gain in patients with OSA and the presence of pharyngeal narrowing during central apnoeas. Indeed, treatment of OSA, whether via continuous positive airway pressure (CPAP), tracheostomy or oral appliances, can reveal CSA, an occurrence referred to as complex sleep apnoea. Factors influencing loop gain include increased chemosensitivity (increased controller gain), reduced damping of blood gas levels (increased plant gain) and increased lung to chemoreceptor circulatory delay. Sleep-wake transitions and pharyngeal dilator muscle responses effectively raise the controller gain and therefore also contribute to total loop gain and overall instability. In some circumstances, for example apnoea of infancy and central congenital hypoventilation syndrome, central apnoeas are the consequence of ventilatory depression and defective ventilatory responses, that is low loop gain. The efficacy of available treatments for CSA can be explained in terms of their effects on loop gain, for example CPAP improves lung volume (plant gain), stimulants reduce the alveolar-inspired PCO2 difference and supplemental oxygen lowers chemosensitivity. Understanding the magnitude of loop gain and the mechanisms contributing to instability may facilitate personalized interventions for CSA.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Orr JE, Malhotra A, Sands SA, et al. Pathogenesis of central and complex sleep apnoea. Respirology. 2016. PMID: 27797160. doi:10.1111/resp.12927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。